Clinical Trial Update: The Use of Hepatitis C Positive Livers in Hepatitis C Negative Liver Transplant Recipients [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluated transplanting hepatitis C–positive livers into hepatitis C–negative liver transplant recipients. The study has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis C

Snippet

Sponsor: Fernanda P Silveira, MD, MS | Conditions: Liver Transplant, Hepatitis C | Phase 2 | Status: COMPLETED